No Data
No Data
China Merchants Securities: Profit performance is better than revenue, and top OTC brands have stronger resilience.
In the first half of 2024, high-end scarce resources and traditional Chinese medicine OTC enterprises with brand and channel barriers performed well, while hospital-based traditional Chinese medicine enterprises were under short-term pressure due to industry policies and other factors.
Only Three Days Left To Cash In On Dong-E-E-JiaoLtd's (SZSE:000423) Dividend
Dong-E-E-Jiao (000423.SZ): The semi-annual equity distribution for 2024 is 10 payments of 11.47 yuan. Ex-right and ex-dividend date is September 10th.
On September 3, GeLongHui announced that the company's equity distribution plan for the first half of 2024 is as follows: Based on the total existing share capital of 643,976,824 shares, excluding the repurchased shares of 1,512,400 shares, the base number of shares is 642,464,424 shares, and a cash dividend of 11.466930 yuan per 10 shares will be distributed to all shareholders. The equity distribution registration date for this distribution is September 9, 2024, and the ex-dividend date is September 10, 2024.
Dong-E-E-JiaoLtd (SZSE:000423) Shareholders Have Earned a 11% CAGR Over the Last Five Years
Dong-E-E-Jiao H1 Profit Up 39%, Operating Income Rises 27%; Shares Climb 3%
Dong-E-E-Jiao: Half-year report for the year 2024.
No Data
No Data